Skip to search formSkip to main contentSkip to account menu

Cloretazine

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

VNP 40101Mlaromustine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Effects of the anticancer agent Cloretazine on human apurinic endonuclease-1 activity
The carbamolyating activity of Clore~ine, a novel anticancer prodrug, modifies protein function and acts synergistically with the… 
2008
2008
TREATMENT WITH VNP40101M (CLORETAZINE?) IN PATIENTS WITH HIGH RISK MYELODYSPLASTIC SYNDROMES (MDS): RESULTS OF A SUBSET POPULATION IN A PHASE II STUDY
2006
2006
A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with relapsed AML following a short initial complete remission
2006
2006
Single agent cloretazine is an effective induction therapy in elderly patients (pts) with poor risk AML